 |
|
The potential risks of sugammadex
Wonjin Lee
Anesth Pain Med. 2019;14(2):117-122. Published online 2019 Apr 30 DOI: https://doi.org/10.17085/apm.2019.14.2.117
|
|
Citations to this article as recorded by
 The immunomodulatory effect of sugammadex in vitro and after total hip arthroplasty
Veerle Bijkerk, Lotte M.C. Jacobs, Jetze Visser, Esmee V. van Helden, Christiaan Keijzer, Leonie S. Helder, Kim I. Albers, Michiel C. Warlé
European Journal of Anaesthesiology.2025; 42(8): 676. CrossRef Sugammadex for our little ones: a brief narrative review
Soomin Lee, Woosuk Chung
Anesthesia and Pain Medicine.2024; 19(4): 269. CrossRef Fetal Outcomes With and Without the Use of Sugammadex in Pregnant Patients Undergoing Nonobstetric Surgery: A Multicenter Retrospective Study
S. Noguchi, H. Iwasaki, Y. Shiko, Y. Kawasaki, Y. Ishida, S. Shinomiya, R. Ono Uokawa, Y. Mazda
Obstetric Anesthesia Digest.2023; 43(4): 184. CrossRef Cardiac effects of Sugammadex and Rocuronium combination in rats: experimental study
Mevlüt DOĞUKAN, Nezir YILMAZ, Ebru ANNAÇ, Zümrüt DOĞAN, Fatih ÜÇKARDEŞ, Öznur ULUDAG
Anatolian Current Medical Journal.2022; 4(3): 244. CrossRef Advantages and pitfalls of clinical application of sugammadex
Hyung Young Lee, Ki Tae Jung
Anesthesia and Pain Medicine.2020; 15(3): 259. CrossRef
|